• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

Comprehensive Overview of 3,5-Bis(aminomethyl)benzoic acid dihydrochloride (CAS No. 185963-32-0)

3,5-Bis(aminomethyl)benzoic acid dihydrochloride (CAS No. 185963-32-0) is a highly specialized organic compound widely utilized in pharmaceutical research, biochemical applications, and material science. This compound, characterized by its dihydrochloride salt form, offers enhanced solubility and stability, making it a preferred choice for researchers focusing on drug development and peptide synthesis. Its unique structure, featuring two aminomethyl groups attached to a benzoic acid backbone, enables versatile reactivity, particularly in cross-linking reactions and bioconjugation.

In recent years, the demand for 3,5-Bis(aminomethyl)benzoic acid dihydrochloride has surged due to its pivotal role in targeted drug delivery systems and nanotechnology. Researchers are increasingly exploring its potential in cancer therapeutics, where its ability to form stable conjugates with biomolecules is highly valued. Additionally, its application in proteomics and enzyme immobilization has garnered significant attention, aligning with the growing interest in precision medicine and biocatalysis.

The synthesis of 3,5-Bis(aminomethyl)benzoic acid dihydrochloride involves a multi-step process, ensuring high purity and consistency. Its CAS No. 185963-32-0 serves as a critical identifier in regulatory and commercial databases, facilitating seamless procurement for laboratories worldwide. The compound’s physicochemical properties, including its melting point, solubility profile, and spectral data, are well-documented, supporting its integration into high-throughput screening and combinatorial chemistry workflows.

From an industrial perspective, 3,5-Bis(aminomethyl)benzoic acid dihydrochloride is a key intermediate in the production of advanced polymers and specialty coatings. Its bifunctional nature allows for the creation of cross-linked networks, enhancing the mechanical and thermal properties of materials. This aligns with the rising demand for sustainable materials and green chemistry initiatives, where efficiency and environmental impact are paramount.

For researchers seeking alternatives or derivatives, 3,5-Bis(aminomethyl)benzoic acid (without the dihydrochloride salt) is often compared, though the latter’s superior handling and reactivity make it more desirable for aqueous-phase reactions. Common queries in search engines include "3,5-Bis(aminomethyl)benzoic acid dihydrochloride solubility" and "CAS 185963-32-0 suppliers," reflecting practical concerns in laboratory settings. Addressing these, the compound’s MSDS and technical data sheets are readily available from reputable suppliers, ensuring compliance with safety protocols.

In summary, 3,5-Bis(aminomethyl)benzoic acid dihydrochloride (CAS No. 185963-32-0) stands as a cornerstone in modern scientific endeavors, bridging gaps between organic chemistry, biomedical engineering, and industrial applications. Its adaptability and well-characterized properties position it as a critical tool for innovation in an era dominated by personalized medicine and smart materials.

• 876-03-9(3-(Aminomethyl)benzoic acid hydrochloride)
• 88457-01-6(Benzoic acid, 4-(aminomethyl)-, sodium salt (1:1))
• 56-91-7(4-(Aminomethyl)benzoic acid)
• 25190-67-4(1,3-Benzenedimethanamine, polycondensate with isophthalic acid)
• 2393-20-6(3-(Aminomethyl)benzoic acid)
• 67688-72-6(4-(Aminomethyl)benzoic acid hydrochloride)
• 105995-43-5(3,5-Bis(aminomethyl)benzoic acid)
• 152768-98-4(8-(Aminomethyl)naphthalene-2-carboxylic acidHydrochloride)
• 162051-35-6(Benzoic acid, 3-(aminomethyl)-, monosodium salt)
• 34243-68-0(Benzoic Acid;phenylmethanamine)